Anti-CD4 monoclonal antibody (Immunotech)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-CD4 monoclonal antibody (Immunotech)
Drug Alias Nameanti-idiotype monoclonal antibody
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionT-cell surface antigen CD4 inhibitors
TargetsT-cell surface antigen CD4
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesImmunotech SAS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunotech SAS
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A